The Institute, a 501(c)(6) non-profit corporation, is an
independent, private-sector, self-sustaining coalition.
The Institute includes in its membership major
employers and employer organizations, including
leading American companies in the petrochemical,
manufacturing, high technology, construction, pharmaceutical,
hospitality, retail, and transportation
industries, and many trade associations and community
coalitions representing businesses of all sizes.
The Institute is active on legislative, legal, and regulatory
issues at the federal, state, and local levels; has
an extensive publications agenda; and has an active
membership services program of action.
The Institute for a Drug-Free Workplace exists because
there are serious threats to American employers and
employees from drug abuse and its tragic human and economic
costs. These threats include: (1) ignorance or
complacence about the dangers of drug and alcohol
abuse to the employer and its employees; (2) anti-drug testing
legislation; (3) legal challenges; (4) regulations
which unduly restrict employer programs; (5) misinformation
or ignorance about drug testing; and (6) legalization
Program of Action
The Institute for a Drug-Free Workplace educates employers,
employees, legislators, public officials, the courts,
the media, and the public at large about: (1) the dangers
of substance abuse; (2) the impact of substance abuse on
the workplace; (3) the most appropriate, effective, and
legally acceptable means for employers to address substance
abuse; (4) the rights and responsibilities of employers
and employees; (5) legislative, regulatory, and legal
developments; and (6) the role of employers in our
national effort to combat substance abuse and its debilitating
The Institute has continually grown each year in its
membership, publications, and program of action. The
Institute frequently advances the employer community’s
position on workplace substance-abuse issues, and has
testified more than 20 times at legislative and regulatory
hearings on drug-testing issues; submitted written statements
more than 50 times; and participated in more
than 15 court cases as an amicus curiae (friend of the court).
The Institute also has been directly involved with the
development, consideration, and passage of legislation
and regulations at both the state and Federal levels. For
example, the Institute’s model state drug-testing law
has been enacted, with minor changes, in five states.
For information about Institute publications and
membership, please e-mail us at
email@example.com, or call (703)391-7222.